Quarterly Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7733573

Concept As at
2017-09-30
As at
2016-12-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,176,975,000 JPY
2,564,045,000 JPY
Work in process
1,550,000 JPY
JPY
Other
65,000 JPY
34,000 JPY
Current assets
3,323,171,000 JPY
2,746,518,000 JPY
Non-current assets
Property, plant and equipment
2,448,000 JPY
JPY
Property, plant and equipment
Investments and other assets
450,015,000 JPY
393,795,000 JPY
Investments and other assets
Investment securities
397,889,000 JPY
351,940,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
452,463,000 JPY
393,795,000 JPY
Assets
3,775,634,000 JPY
3,140,313,000 JPY
Liabilities
Current liabilities
Short-term borrowings
93,336,000 JPY
63,202,000 JPY
Income taxes payable
20,451,000 JPY
24,634,000 JPY
Current liabilities
245,068,000 JPY
204,849,000 JPY
Non-current liabilities
Long-term borrowings
352,774,000 JPY
300,000,000 JPY
Non-current liabilities
365,231,000 JPY
318,080,000 JPY
Liabilities
610,300,000 JPY
522,929,000 JPY
Net assets
Shareholders' equity
Share capital
5,764,213,000 JPY
5,090,981,000 JPY
Deposits for subscriptions of shares
40,000 JPY
JPY
Capital surplus
5,756,713,000 JPY
5,083,481,000 JPY
Retained earnings
-8,348,674,000 JPY
-7,569,313,000 JPY
Shareholders' equity
3,172,291,000 JPY
2,605,149,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-18,091,000 JPY
-8,370,000 JPY
Valuation and translation adjustments
-18,091,000 JPY
-8,370,000 JPY
Share acquisition rights
11,133,000 JPY
20,604,000 JPY
Net assets
3,165,334,000 JPY
2,617,383,000 JPY
Liabilities and net assets
3,775,634,000 JPY
3,140,313,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.